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A B S T R A C T
Diffusion magnetic resonance imaging (dMRI) is an imaging technique which probes the random motion of
water molecules in tissues and has been widely applied to investigate changes in white matter microstructure in
Alzheimer’s Disease. This paper aims to systematically review studies that examined the effect of Alzheimer’s
risk genes on white matter microstructure. We assimilated findings from 37 studies and reviewed their diffusion
pre-processing and analysis methods. Most studies estimate the diffusion tensor (DT) and compare derived
quantitative measures such as fractional anisotropy and mean diffusivity between groups. Those with increased
AD genetic risk are associated with reduced anisotropy and increased diffusivity across the brain, most notably
the temporal and frontal lobes, cingulum and corpus callosum. Structural abnormalities are most evident
amongst those with established Alzheimer’s Disease. Recent studies employ signal representations and analysis
frameworks beyond DT MRI but show that dMRI overall lacks specificity to disease pathology. However, as the
field advances, these techniques may prove useful in pre-symptomatic diagnosis or staging of Alzheimer’s dis-
ease.
1. Introduction
Alzheimer’s Disease (AD) is a progressive neurodegenerative dis-
order affecting older adults. It is characterised by amyloid plaques,
hyperphosphorylated tau and atrophy (Braak and Braak, 1995). His-
topathological studies have also identified AD pathology in white
matter (Englund, Brun and Alling, 1988). In recent years, diffusion
Magnetic Resonance Imaging (dMRI) has been used to examine white
matter microstructure in AD and to study the effect of AD genetic risk
on white matter microstructure.
1.1. Alzheimer’s disease genetic risk
Sporadic AD, often called late-onset AD, is the most common form
of dementia, affecting 1 in ten people over the age of 65 (Alzheimer’s
Association, 2019). The heritability of sporadic AD is estimated to be
between 58 and 79% (Gatz et al., 2006). The largest genome-wide as-
sociation study (GWAS) of clinically confirmed AD has identified 25
loci that are associated with increased risk for sporadic AD (Kunkle
et al., 2019). These are common genetic variants, known as single nu-
cleotide polymorphisms (SNPs). The largest of these genetic risks are
SNPs in the Apolipoprotein E (APOE) region. Carriers of two copies of
the APOE Epsilon 4 (APOE E4) allele have an eight-fold increase in risk
compared to non-carriers (Corder et al., 1993). In comparison to APOE,
other common risk loci have only a modest effect on disease risk.
However, their combined effect can be studied using polygenic risk
scores. These are calculated from the weighted sum of weighted allelic
dosages across the genome, and have proven particularly effective in
predicting AD (Escott-Price et al., 2015). In addition to common genetic
risk captured by GWAS, advances in sequencing techniques have as-
sessed entire exomes and genomes, identifying rare mutations with
moderate-to-strong effects. For example, TREM2 is a variant that en-
codes the trigger receptor expressed on myeloid cells 2 (Guerreiro et al.,
2013). Other novel variants are involved in immune response and
transcriptional regulation (Bis et al., 2018).
Whilst sporadic AD occasionally occurs in people under the age of
65, autosomal-dominant AD is characterised by an early clinical onset.
In contrast to sporadic AD, autosomal-dominant AD is rare (Alzheimer’s
Association, 2019). It is caused by mutations either in the amyloid
precursor protein (APP) gene, or in presenilin 1 and 2 (PS1 and PS2)
that are involved in cleaving amyloid β and APP. The disease onset is
often predictable, depending on the specific mutation (Tanzi, 2012).
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1.2. Diffusion MRI
dMRI is a non-invasive imaging method that probes the movement
of water molecules to assess the microstructural configuration of white
matter tracts (Jones, 2011; Winston, 2012). dMRI measures indicate
how readily water molecules can diffuse in and around structures such
as white matter fibres or cell bodies (Stejskal and Tanner, 1965; Bihan,
1995; Strijkers, Drost and Nicolay, 2011; Johansen-Berg and Behrens,
2013). In white matter, the rate of diffusion is modulated by multiple
microstructural features including axon diameter, axon density and
myelination (Jones, 2011). In highly ordered white matter, the rate of
diffusion is anisotropic, i.e., it is strongly dependent on the direction in
which it is measured. The commonly index of anisotropy is the frac-
tional anisotropy (FA) introduced by Basser and Pierpaoli (Basser and
Pierpaoli, 1996). An FA of 0 indicates that the rate of diffusion is the
same in all directions (isotropic diffusion), and 1 represents the extreme
case where diffusion can only occur along one axis (anisotropic diffu-
sion) (Beaulieu and Allen, 1994; Pierpaoli and Basser, 1996; Beaulieu,
2009; Winston, 2012). Clinical studies often employ this as a measure
of tissue integrity (Thomason and Thompson, 2011), although at best
this interpretation is an oversimplification (Jones, Knösche and Turner,
2013). Another widely used metric is mean diffusivity (MD), which
represents the orientationally-averaged rate of diffusion. Additional
commonly used metrics from DTI are the ‘longitudinal diffusivity’ (LD)
and ‘radial diffusivity’ (RD), which in turn represent the highest and
lowest rates of diffusion. In the case of perfectly aligned axonal bundles,
these would represent diffusivity parallel and perpendicular to the main
axis of the bundle, respectively. However, given the ubiquity of mul-
tiple fibre populations within an image voxel, this interpretation carries
some risk (see: Wheeler-Kingshott and Cercignani, 2009) but also see
(Wheeler-Kingshott et al., 2012)). Collectively, FA, MD, LD and RD can
help to characterise changes in diffusion resulting from differences in
white matter microstructure.
1.3. Structural changes observed in Alzheimer’s disease
Conventional MRI measures of atrophy, such as Voxel-Based
Morphometry (VBM), are established markers for AD diagnosis and
measurement of progression (Frisoni et al., 2010). More recently, dMRI
has allowed the exploration of AD white matter microstructure, finding
widespread changes. A meta-analysis of 41 studies found reduced FA
and increased MD in AD brains compared to controls. Differences were
marked in frontal and temporal lobes, and the posterior cingulum,
corpus callosum, superior longitudinal fasiculi and uncinate fasiculi
(Sexton et al., 2011). Late-myelinating tracts may be affected primarily
by AD neurodegeneration (Benitez et al., 2014). Longitudinal studies
suggest that the pattern of decreased FA and increased MD becomes
more distinct as the disease progresses (Mayo et al., 2017). Changes in
the parahippocampal cingulum have been shown to discriminate be-
tween AD and healthy controls (Mayo et al., 2017). Diffusion mea-
surements in the fornix are another possible biomarker (Ringman et al.,
2007). Perea and colleagues found that AD preferentially degraded the
crus and body of the fornix. The diffusion differences remained after
controlling for fornix volume (Perea et al., 2018).
Mild Cognitive Impairment (MCI) describes a degree of cognitive
problems that do not affect day-to-day living, and are considered to be
an AD prodrome (Petersen and Morris, 2005). A meta-analysis of 41
studies found that compared to healthy controls, patients with MCI had
lower FA in all white matter areas except parietal and occipital regions,
and higher MD except in occipital and frontal regions (Sexton et al.,
2011). More recently, whole brain white matter histogram analysis
found that RD, LD and MD were able to discriminate between AD and
controls and between MCI and controls in the ADNI cohort. LD ap-
peared to be the most sensitive marker (Giulietti et al., 2018).
dMRI metrics in the fornix are markers of cognitive problems, and
can distinguish MCI from AD (Egli et al., 2015; Tang et al., 2017). The
volume of the body of the fornix and LD in the fornix are correlated
with decline from normal cognition (Fletcher et al., 2013). Reduced FA
in the fornix can predict conversion both from healthy cognition to MCI
and from MCI to AD with high specificity and > 90% accuracy (Mielke
et al., 2012; Oishi et al., 2012). Reduced FA and increased MD in the
fornix might even precede hippocampal atrophy (Zhuang et al., 2012).
1.4. Current review
This systematic review aimed to collate studies applying diffusion
MRI techniques to investigate genetic risk for AD. In our narrative
synthesis, our goal is to assess the evidence for manifestations of
Alzheimer’s genetic risk in white matter microstructure. We also aim to
review the studies in terms of their study design and diffusion metho-
dology, including pre-processing and analysis.
2. Methods
We conducted this systematic review in accordance with PRISMA
guidelines (Moher et al., 2009).
2.1. Study selection
Initially, we defined our search terms (listed in Table 1,
Supplementary Materials). We searched the literature using MEDLINE,
PSYCHINFO and EMBASE from January 2000-July 2019. We hand-
searched the reference lists of related articles.
Inclusion criteria:
• Case-control, cross-sectional or longitudinal studies
• Genotyped participants
• Imaged with dMRI sequences
• Associations reported between AD risk genes/SNPs and measures
derived from dMRI
Exclusion criteria:
• Publications in non-English language journals
• Conference proceedings
• Studies of non-Alzheimer’s dementia or unspecified dementia
• Studies using family history and genotype as a composite variable
• Studies using MRI but not including dMRI
• Studies investigating genes/SNPs that are not associated with AD
risk
• Studies that co-vary for AD genes (e.g. APOE) but that do not report
associations with AD risk genes/SNPs
2.2. Article selection
The articles included in this review are all English language original
research papers. Study designs included case-control, cross-sectional
and longitudinal studies. The primary search was conducted by SB. Five
reviewers (SB, HB, AMD, ZXT, JH) all independently selected studies
based on the eligibility criteria. Disagreements were resolved by con-
sensus.
2.3. Data extraction
Reviewers (SB, HB, AMD, ZXT, JH) extracted information from
papers independently. Data were extracted from each study in duplicate
to ensure consistency. Key data included: study design and number of
participants the AD genetic risk measured; MRI acquisition parameters;
dMRI pre-processing; dMRI analysis techniques; reported findings. A
complete list of the data extracted can be found in Supplementary
Materials Table 2.
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2.4. Quality assessment
The quality of each included study was assessed independently by
two reviewers using the appropriate version of the Newcastle-Ottawa
Scale (NOS) (Stang, 2010) for the study design (case/control, cross-
sectional or cohort study). The NOS assesses the quality of non-rando-
mized studies in three main areas: the selection of study groups; the
comparability of the groups; and the ascertainment of the exposure or
outcome of interest. This tool was chosen because of the type of studies
included. A consensus meeting between all reviewers established a
manual to ensure this was applied consistently. The assessment tool was
adapted to fit the included studies, where the exposure was defined as
genetic risk, and important covariates were age, sex and APOE e4
status. A point was awarded in each category.
3. Results
3.1. Search results
We identified 2931 articles in our initial search (see PRISMA flow
diagram in Fig. 1). We excluded duplicates, non-English language, non-
human studies and conference proceedings. 2514 articles were screened
based on their titles and abstracts and a further 2394 were excluded.
The reviewers (SB, HB, AMD, ZXT, JH) reviewed the full text of 120
articles and applied the inclusion criteria. 32 studies met the criteria for
inclusion. A further 4 studies were identified through hand-searches of
reference lists.
3.2. Study characteristics: Study design, sample, Alzheimer’s genetic risks
The majority of the studies were case/control design, although some
were cross-sectional (Foley et al., 2016) and some longitudinal cohort
studies (Lyall et al., 2014). Some studies were conducted using the same
cohorts: three used data from the Beijing Aging Brain Rejuvenation
Initiative (BABRI); two used the Wisconsin Registry for Alzheimer’s
Prevention (WRAP); two used the European Diffusion Tensor Imaging
Study on Dementia (EDSA) and the DZNE database, Rostock, Germany.
Only one article reported data from the Alzheimer’s Disease Neuroi-
maging Initiative (ADNI). Most studies included participants who were
pre-symptomatic. Only ten included those with established AD or MCI.
3.3. Genotypes
Two approaches were used to assess genetic risk for AD. Most stu-
dies tested participants for specific mutations (APP, PS1/2 mutations or
APOE alleles). One study used an array to genotype participants and
calculate polygenic risk scores based on sporadic AD GWAS (Foley
et al., 2016).
3.4. dMRI pre-processing and analysis methods
Prior to modelling or statistical analysis, it is essential to pre-process
the dMRI data, correcting for artefacts, motion and eddy-current in-
duced distortions (Jones, Knösche and Turner, 2013). Once pre-pro-
cessed, different approaches can be applied to represent the dMRI
signal. Beyond the diffusion tensor framework, two common ways to
represent the orientation dependence of the signal in dMRI are the
Fig. 1. PRISMA flow chart.
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diffusion orientation density function (dODF) (Wedeen et al., 2005) and
the fibre orientation density function (fODF) (Dell’Acqua et al., 2019).
The diffusion ODF is a spherical function which characterises the
probability of diffusion along a unit direction. On the other hand, the
fODF is a function that characterises the probability of finding a fibre
oriented along a particular axis (Jones et al., 2013).
An additional method, known as neurite orientation dispersion and
density imaging (NODDI), aims to provide more specific micro-
structural information (Zhang et al., 2012). NODDI assumes there are
three biophysical compartments in white matter, intra-cellular, extra-
cellular and cerebrospinal fluid, in a single voxel. By imposing con-
straints on some of the parameters that describe these compartments,
NODDI aims to estimate proxies of intracellular volume fraction (IVF),
neurite density index (NDI), orientational dispersion index (NDI) and
increased free isotropic water fraction (FISO) (Zhang et al., 2012).
Quantitative dMRI measures, such as FA, MD, RD and LD (all de-
rived from the diffusion tensor), can be analysed using tractography or
whole-brain voxel-wise analysis. Tractography involves reconstructing
the trajectory of fibres and connection patterns, using either the prin-
cipal eigenvector of the diffusion tensor, or peaks in the dODF or fODF,
within successive adjacent voxels (Tournier, Mori and Leemans, 2011;
Jones, Knösche and Turner, 2013). These local orientations are used to
infer total fibre trajectories (Jeurissen et al., 2019). Commonly used
methods include deterministic and probabilistic tractography. In de-
terministic tracking, a path is propagated along local maxima of the
ODF (or, in the case of diffusion tensor imaging, along the principal
eigenvector). However, imaging noise and artifacts can make estimates
of local maxima imprecise and adds some local orientational un-
certainty. Probabilistic tractography techniques illustrate these un-
certainties by assigning an uncertainty, or conversely, a probability to
the orientational estimates. As such, each local maximum in an ODF can
generate a collection of possible trajectories (Jeurissen et al., 2019).
A tractography-based region-of-interest (ROI) approach allows the
researcher to define ‘seeds’ to begin fibre tracking, or to define ‘way-
points’ that prescribe regions through which a reconstructed tract must
pass in order to be retained for analysis (Conturo et al., 1999). These
can be drawn manually or automatically. Alternatively, whole-brain
tractography places seeds throughout the whole brain (Soares et al.,
2013), again using ‘way-point’ ROIs to filter out target pathways. In
tractography, each tract is segmented in the native of the individual
(rather than requiring that the individual’s data are co-registered to
some standardised template space, providing a representation of tract
anatomy for each individual (Bastin et al., 2013)). It is important to
recognise that the reconstructed tracts do not represent nerve fibres or
fibre bundles directly. Rather, they represent pathways or trajectories
through the signal, and we infer that the nerve fibres run approximately
in parallel. These pathways can be translated into qualitative in-
formation, e.g., on the tract shape, and into quantitative information, as
measures averaged along the tract (Jones and Pierpaoli, 2005) or in
assessing the extent of connections between brain regions (Kaden,
Knösche and Anwander, 2007).
Whole brain voxel-based techniques, such as Tract Based Spatial
Statistics (TBSS) (Smith et al., 2006, 2007) or Voxel-Based Analysis
(VBA) (Büchel et al., 2004; Van Hecke et al., 2009), are an alternative
approach to tractography. They typically involve the nonlinear regis-
tration of quantitative diffusion tensor imaging maps, (e.g. FA), from
each individual to a standard template space. The aligned FA images
are then averaged, and a skeletonised mean FA structure is created.
Thresholds are applied to suppress areas of low mean FA or high inter-
subject variation. Each subject's FA image is then projected onto the
skeleton, and voxel-wise statistics can be carried out across subjects. For
comprehensive descriptions of these different dMRI methods and pos-
sible pitfalls, please see (Smith et al., 2006; Jones, Knösche and Turner,
2013; Soares et al., 2013).
Inter-regional connectivity can be assessed by constructing net-
works of the human brain using diffusion signals and tractography (Yeh
et al., 2020). The resultant networks can be characterised using graph
theoretical approaches. Graph theory is a mathematical framework for
representing complex networks. The brain can be illustrated using
nodes, representing regions or voxels, and edges, representing con-
nections between nodes (Bullmore and Sporns, 2009). A number of
network metrics can be produced such as small-world and network
efficiency. Please see (Boccaletti et al., 2006) for a detailed summary of
graph theory.
The studies that met our inclusion criteria used a range of dMRI
analysis methods. 15 used TBSS, seven used a tractography-based ROI
approach, eight used VBA, three combined TBSS and VBA, one com-
bined TBSS and ROI, and three calculated structural connectivity ma-
trices.
3.5. Studies of white matter structure and APOE status
The majority of the papers which met our inclusion criteria explored
the effects of APOE (27 articles). Most used a case-control design, al-
though some were longitudinal studies. There was a wide range of
sample sizes (N range=14–885). The literature predominantly ex-
amined samples of cognitively healthy older adults (age > 60). Five
studies included participants with diagnoses of AD or MCI (Bagepally
et al., 2012a,b; Kljajevic et al., 2014; Wai et al., 2014; Ma et al., 2017;
Slattery et al., 2017). Studies of younger age groups included adoles-
cents (Dell’Acqua et al., 2015), adults in their 20′s (Heise et al., 2011;
O’Dwyer et al., 2012; Dowell et al., 2013), 40′s and 50′s (Westlye et al.,
2012; Operto et al., 2018). Some studies were able to compare groups
with different combinations of APOE alleles (Lyall et al., 2014), al-
though most simply compared APOE E4 carriers (homozygotes and
heterozygotes) to those without an E4 allele. Diffusion methodology
included: TBSS (12 studies); tractography-based ROI (6 studies); VBA (4
studies); TBSS and VBA (3 studies); TBSS and ROI (1 study); structural
connectivity (3 studies). Table 1 provides a summary of studies ex-
ploring white matter metrics and APOE genotype.
Five studies reported no significant differences in white matter
microstructure between carriers and non-carriers (Honea et al., 2009;
Bendlin et al., 2012; Nyberg and Salami, 2014; Dell’Acqua et al., 2015;
Wang et al., 2015). All other studies reported some significant changes
in diffusion metrics associated with APOE4. The pattern of alteration in
affected tracts or regions was similar to studies of autosomal-dominant
AD genes: reduced FA was commonly reported, often in tandem with
increased MD, RD or LD. Reduced neurite density index (NDI) and in-
creased free isotropic water fraction (FISO) are also reported. The white
matter regions found to be associated with APOE status included: the
genu (Newlander et al., 2014; Zhang et al., 2015; Cai et al., 2017;
Cavedo et al., 2017), body (Persson et al., 2006; Zhang et al., 2015) and
splenium (Ryan et al., 2011; Slattery et al., 2017) of the corpus cal-
losum and the corpus callosum overall (Heise et al., 2011; Westlye
et al., 2012; Cavedo et al., 2017); the parahippocampal cingulum
(Nierenberg et al., 2005; Bagepally et al., 2012a,b; Kljajevic et al.,
2014; Zhang et al., 2015) and the cingulum overall (Adluru et al., 2014;
Lyall et al., 2014; Cavedo et al., 2017); the intracalacrine sulcus
(Bagepally et al., 2012a,b; Westlye et al., 2012); the brain stem
(Westlye et al., 2012; Newlander et al., 2014); the corona radiata (Heise
et al., 2011; Smith et al., 2016; Cai et al., 2017; Cavedo et al., 2017;
Slattery et al., 2017; Operto et al., 2018); the external capsule (Heise
et al., 2011; Cavedo et al., 2017) and internal capsule (Heise et al.,
2011; Westlye et al., 2012; Smith et al., 2016; Cavedo et al., 2017); the
superior longitudinal fasciculus (Adluru et al., 2014; Lyall et al., 2014;
Cavedo et al., 2017; Operto et al., 2018) and inferior longitudinal fas-
ciculus (Dowell et al., 2013; Cavedo et al., 2017); the fronto-occipital
fasiculus (Cavedo et al., 2017; Operto et al., 2018); the fornix (Zhang
et al., 2015); the cerebral peducles (Zhang et al., 2015); the cortico-
spinal tract (Laukka et al., 2015); the uncinate fasiculus (Salminen
et al., 2013); the forceps major (Laukka et al., 2015) and forceps minor
(Operto et al., 2018).
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Three papers used measures of structural connectivity based on
graph theory. Brown et al found that APOE E4 carriers had age-related
loss of mean local interconnectivity and regional local interconnectivity
in the precuneus, medial orbitofrontal cortex, and lateral parietal cortex
(Brown et al., 2011). Ma et al studied participants with MCI and with
normal cognition. They found that healthy APOE E4 carriers had in-
creased clustering coefficient and local efficiency compared to healthy
non-carriers. In those with MCI, carriers showed decreased clustering
coefficient and local efficiency relative to MCI non-carriers. When all
carriers were compared to all non-carriers, they showed decreased
nodal efficiency in the inferior frontal gyrus, the left superior frontal
gyrus, and the left middle occipital gyrus. Carriers also showed in-
creased nodal efficiency in the left cuneus, the left inferior parietal,
supramarginal and angular gyri (Ma et al., 2017). A further study re-
ported that E4 carriers had lower global efficiency but no significant
differences in local efficiency. Decreased nodal efficiency in left ante-
rior cingulate, left paracingulate gyrus, right dorsolateral superior
frontal gyrus, and left inferior occipital gyrus was reported in carriers
relative to non-carriers. In addition, they used structural connectivity
measures to predict AD with Receiver-Operator Curves (ROC). Using
global efficiency, they produced an Area Under Curve (AUC) of 0.74.
Using mean nodal efficiency of significant decreasing regions, this im-
proved to 0.81 (Chen et al., 2015).
3.6. Studies of white matter and autosomal-dominant AD genes
Six studies explored white matter metrics in participants with au-
tosomal-dominant AD genes: three studied PS1 carriers, two studied
APP and PS1 carriers and one studied PS1, PS2 and APP carriers. All
used a case/control design. They compared pre-symptomatic and
symptomatic gene carriers to non-carriers. Sample sizes reflect the
rarity of the genes (N range= 20–109, of which 10–64 were carriers).
Three studies used VBA, three used TBSS.
Of the three studies of PS1 carriers, one study identified reduced MD
and LD in the right cingulum among pre-symptomatic carriers (Ryan
et al., 2013), and the other two studies reported no significant differ-
ences between pre-symptomatic PS1 and non-carriers (Parra et al.,
2015; Sanchez-Valle et al., 2016). In symptomatic PS1 carriers, changes
included: increased MD, RD and LD and reduced FA in all the fornix,
cingulum and corpus callosum (Ryan et al., 2013); higher MD in the left
inferolateral frontal white matter, right parahippocampal cingulum
bundle, splenium left of the mid-line and genu symmetrically around
the mid-line of the callosum (Parra et al., 2015); decreased FA in the
genu and body of corpus callosum and corona radiata bilaterally and
increased MD, LD, and RD in the splenium of corpus callosum relative
to age (Sanchez-Valle et al., 2016).
Two studies with mixed cohorts of PS1 or APP carriers reported a
number of changes in pre-symptomatic carriers: reduced FA in the
fornix and frontal white matter (Ringman et al. 2007); increased MD in
the left inferior longitudinal fasciculus, left forceps major, left cingulum
and bilateral superior longitudinal fasciculus (Li et al., 2015). In the
same PS1/APP studies, symptomatic carriers showed: decreased mean
FA across the whole brain, especially in the left frontal white matter,
and right and left perforant paths (Ringman et al. 2007); increased MD
in the inferior longitudinal fasciculus, forceps major, cingulum and
bilateral superior longitudinal fasciculus (Li et al., 2015). The effects
seen in the symptomatic APP/PS1 carriers were greater and more
widespread than in pre-symptomatic carriers (Ringman et al., 2007; Li
et al., 2015). Caballero et al studied a large mixed cohort of PS1/2 and
APP carriers. They found increased MD in the forceps minor, forceps
major and long projecting fibres 5–10 years before the estimated onset
of symptoms (Caballero et al., 2018). See Table 2 for a summary of
these studies.
3.7. Studies of white matter and AD risk loci from GWAS
Three studies correlated white matter metrics with AD risk loci
identified through GWAS. One was cross-sectional and two were case/
control studies. They all included healthy participants (Mean age range
23.6–72.7; N range 197–645). Two studies used an ROI approach, one
used VBA.
Braskie et al. imaged healthy young adults and found that each C
allele copy of the CLU allele was associated with lower FA in the
splenium of the corpus callosum, the fornix, cingulum, and superior and
inferior longitudinal fasciculi bilaterally (Braskie et al., 2011). The
Lothian Birth cohort study identified lower FA associated with different
length genotypes of the poly-T repeat in TOMM40. Shorter genotypes
were significantly associated with lower FA in the right rostral cin-
gulum and left ventral cingulum. This effect was independent of APOE
genotype (Lyall et al., 2014). Foley et al used an Alzheimer’s polygenic
score, the weighted sum of the risk loci from GWAS, as a continuous
variable. They identified an association between increased AD poly-
genic score and decreased FA in the right cingulum in young adults
(Foley et al., 2016).
Elliot et al undertook a GWAS of brain imaging phenotypes in the
UK Biobank cohort (Elliott et al., 2018). They used imaging data from
around 15,000 participants. All results are available on the Oxford
Brain Imaging Genetics (BIG) web browser (http://big.stats.ox.ac.uk/).
The BIG website can be browsed associations by phenotype, gene or
SNP. We explored the associations between AD risk loci identified in the
Kunkle at al GWAS (Kunkle et al., 2019) and FA/MD derived from TBSS
in UK Biobank. A table summarising these results is provided in the
Supplementary Materials. Broadly, the results corroborate the findings
of other studies included in this review. APOE and CR1 showed parti-
cular evidence of association with reduced fractional anisotropy and
increased mean diffusivity. However, these results are not corrected for
multiple comparisons.
3.8. Study quality overview
Most studies scored highly on the NOS. Generally, the comparability
of the groups was clearly explained. As the exposure was gene status,
there was little possibility of ascertainment bias. Some studies had one
point deducted for failing to describe the selection of study groups,
particularly of control subjects. The outcomes of interest (white matter
metrics) were defined, although the methodology employed to measure
these was variable. It was often difficult to assess the quality of the
diffusion methodology, as authors often did not provide sufficient in-
formation. Most studies gave some details of their pre-processing, al-
though one acknowledged they had not corrected for Gibbs ringing, a
common artefact (Gibbs, 1898). The papers generally did not give de-
tails of their model estimation technique (for example nonlinear least
squares (NLLS), weighted linear least squares (WLLS) or ordinary least
squares (OLS)), which can lead to different outcomes (Koay et al.,
2006). The majority of studies, 27 of 37, used TBSS or VBA. Of those
papers that used tractography, only some described or referenced the
specific methods (such as deterministic or probabilistic).
4. Discussion
This review establishes that the literature reports AD genetic risk is
related to altered white matter microstructure, as indexed by increased
diffusivity and decreased anisotropy. By synthesising results across
studies, this review demonstrates that AD risk genes were associated
with widespread white matter changes, rather than discrete micro-
structural abnormalities in medial temporal structures such as the
fornix. This review also found evidence of changes related to AD risk
even in studies of young, healthy adults.
J.R. Harrison, et al. NeuroImage: Clinical 27 (2020) 102359
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4.1. White matter changes associated with AD risk genes
AD genetic risk is associated with reduced anisotropy and increased
diffusivity across the brain, most notably in temporal and frontal lobes,
cingulum and corpus callosum. Table 3 contains a summary of the five
tracts that were implicated in the most studies (tract images were
generated using FiberNavigator (Chamberland et al., 2014) and
TractSeg (Wasstheral et al., 2018)). Although some studies reported no
differences between pre-symptomatic gene carriers and non-carriers,
many of these studies were limited by small sample sizes. Differences
between symptomatic carriers and non-carriers frequently paralleled
the differences between pre-symptomatic carriers and non-carriers, but
in the pre-symptomatic group often fewer regions reached statistical
significance or effect sizes were smaller.
The literature included in this review reported diffuse changes in
white matter signal and global structural connectivity. These reflect the
changes across regions and hemispheres that underpin emergent AD.
There was significant overlap between the regions implicated by studies
of APOE, autosomal-dominant AD genes and GWAS loci. This suggests
that although these genes are involved in different biological processes,
these pathways may converge on a common final pathway resulting in a
corresponding pattern of neurodegeneration. This is in keeping with the
literature on AD pathology (Naj and Schellenberg, 2017). However,
there was no evidence that microstructural changes were related to any
individual microstructure component, as abnormalities were evident
across white matter metrics.
4.2. Methodological considerations
The field has some key limitations (Jones and Cercignani, 2010;
Jones, Knösche and Turner, 2013). Firstly, water diffusion is not a di-
rect measure of neuroanatomy. Secondly, dMRI is an intrinsically noise-
sensitive and low-resolution technique (Jones, Knösche and Turner,
2013). Several dMRI models assume fibre bundles to run parallel in a
tract. However, fibres cross perpendicularly within voxels in many
brain regions, which reduces the FA. The percentage of voxels con-
taining crossing fibres is estimated to be∼ 90% (Jeurissen et al., 2013).
It is also difficult to separate tracts that are closely aligned and then
Table 3
Summary of key findings for the most commonly implicated tracts by gene risk (APOE or FAD).
Tract Diagram Summary of APOE Findings Summary of FAD Findings
Corpus Callosum:
Connects the left and right cerebral
hemispheres
E4 carriers vs. non-carriers:
↓FA (Persson et al, 2006, Newlander et al, 2014, Heise et al,
2010, Cavedo et al, 2017, Zhang et al, 2015, Ryan et al,
2011, Slattery et al, 2017)‘↑MD (Heise et al, 2010, Cavedo
et al, 2017, Cai et al, 2017, Zhang et al, 2015)
↑RD (Cavedo et al, 2017, Westlye et al, 2012)
Pre-symptomatic carriers vs.
controls:
↓FA (Sanchez-Valle et al,
2016)
Symptomatic carriers vs.
controls:
↑MD (Sanchez-Valle et al,
2016, Parra et al, 2015)
↑LD (Sanchez-Valle et al,
2016)
↑RD (Sanchez-Valle et al,
2016)
Cingulum:
Connects the temporal and frontal lobes,
cingulate and medial gyri of frontal, occipital,
parietal and temporal lobes
E4 carriers vs. controls:
↓FA (Lyall et al, 2014, Bagepally et al, 2012, Heise et al,
2010, Cavedo et al, 2017, Nierenberg et al, 2005)
↑MD (Li et al, 2012, Zhang et al, 2015, Cavedo et al, 2017
Adluru et al, 2014)
↑RD (Cavedo et al, 2017, Nierenberg et al, 2005)
Pre-symptomatic carriers vs.
controls:
↓MD (Ryan et al, 2013)
↑MD (Li et al, 2012)
↓LD (Ryan et al, 2013)
Symptomatic carriers vs.
controls:
↓FA (Ryan et al, 2013)
↑MD (Ryan et al, 2013, Parra
et al, 2015, Li et al, 2012)
↑LD (Ryan et al, 2013)
Inferior Occipito-Frontal Fascicle:
Connects the medial temporal lobe and the
inferior frontal lobe
E4 carriers vs. non-carriers:
↓FA (Persson et al, 2006, Cavedo et al, 2017)
↑MD (Operto et al, 2018)
↑LD (Operto et al, 2018)
↑RD (Cavedo et al, 2017, Westlye et al, 2012, Operto et al,
2018)
No significant findings
Superior Longitudinal Fascicle:
Connects the frontal, parietal, occipital and
temporal lobes
E4 carriers vs non-carriers:
↓FA (Heise et al, 2010)
↑MD (Adluru et al, 2014, Operto et al, 2018, Cavedo et al,
2017, Heise et al, 2010)
↑RD (Operto et al, 2018, Westlye et al, 2012)
↑LD (Operto et al, 2018)
Pre-symptomatic carriers vs
non-carriers:
↑MD (Li et al, 2012)
Symptomatic carriers vs non-
carriers:
↑MD (Li et al, 2012)
Inferior Longitudinal Fascicle:
Connects the occipital pole and temporal
pole
E4 carriers vs non-carriers:
↓FA (Lyall et al, 2014, Cavedo et al, 2017)
↑MD (Operto et al, 2018)
↑RD (Operto et al, 2018, Dowell et al, 2013, Cavedo et al,
2017)
↑LD (Operto et al, 2018)
Pre-symptomatic carriers vs
non-carriers:
↑MD (Parra et al, 2015, Li
et al, 2012)
Symptomatic carriers vs non-
carriers:
↑MD (Li et al, 2012)
Acronyms: E4=APOE Epsilon 4; FAD=Familial Alzheimer’s Disease; FA= Fractional Anisotropy; MD=Mean Diffusivity; RD=Radial Diffusivity;
LD=Longitudinal Diffusivity. Tract images were generated using FiberNavigator (Chamberland et al., 2014) and TractSeg (Wasserthal et al., 2018).
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diverge (Tournier et al., 2011). DTI also demonstrates ‘degeneracy’: the
same change in the diffusion tensor can be explained by multiple pro-
cesses e.g., differently oriented fibre populations (‘crossing fibres’), or
the ratio intra/extra-axonal space (see Fig. 2). Therefore dMRI is sen-
sitive but lacks specificity (Jelescu et al., 2016a) and cannot provide an
interpretable marker other than a vague concept of ‘tissue integrity’
(Wheeler-Kingshott and Cercignani, 2009).
4.3. Interpretation of dMRI signal change in AD
In additional to neurodegeneration, a number of different patholo-
gical processes can result in the same changes in diffusion signals.
However, the presence of abnormal dMRI measures in AD correlates
with other AD biomarkers, such as amyloid PET (Kantarci et al., 2014),
CSF amyloid-beta and phosphorylated tau (Amlien et al., 2013; Gold
et al., 2014; Li et al., 2015). Among those with AD, lower Mini-Mental
State (MMSE) scores are associated with a greater effect size for FA in
several brain areas, particularly the parietal region.
There is still much debate about the pathophysiology underpinning
white matter changes in AD. For example, it is not clear whether white
matter alterations are related to, or independent of, gray matter de-
generation in AD. One hypothesis is that changes in white matter mi-
crostructure result from Wallerian degeneration (Coleman, 2005). Ac-
cording to this hypothesis, patterns of white matter alterations should
correspond to grey matter pathology, occurring first in the hippocampal
and entorhinal areas, before extending to wider temporal and parietal
regions (Braak & Braak, 1997). Conversely, the theory of retrogenesis
suggests that those tracts which are last to myelinate are the first to
degenerate (Reisberg et al., 2002; Bartzokis, 2004). In this case, late-
myelinating tracts would be affected first. It was striking that in the
results of our systematic review there were no longitudinal dMRI stu-
dies comparing those at high and low genetic risk at different time
points. Such debates cannot be resolved without serial imaging to assess
dynamic changes in white matter signal.
Caution is required when interpreting diffusion metrics in AD. Some
AD dMRI studies have concluded their findings showed disruption of
myelin rather than axon damage based on the effect on LD relative to
RD (Operto et al. 2018). Indeed, authors of ex-vivo studies in rats (Nevo
et al., 2001) and mice (Song et al., 2002) as well as a small study of
cervical spondylosis patients (Ries et al., 2000) have suggested that a
decrease in LD and increased in RD could potentially be used to dif-
ferentiate demyelination from axonal injury. However, it may not be
safe to generalize findings from controlled animal experiments and
spinal cord studies to human brain, which has complex white matter
architecture. Microstructural dMRI models (Assaf and Basser, 2005;
Panagiotaki et al., 2012; Zhang et al., 2012), which aim to be more
specific than dMRI by describing the signal as arising from a sum of
tissue compartments, hold great promise, but the nonlinear fitting
suffers from poor precision (Jelescu et al., 2016a). Furthermore, mi-
crostructural dMRI models do not account for water in myelin because
it cannot be detected with common dMRI acquisitions. Measuring
myelin content is relevant for monitoring pathologies where demyeli-
nation, dysmyelination and remyelination are implicated. Thus, despite
dMRI signals being modulated by changes in myelin content through
changes in intra/extra-axonal space (Jelescu et al., 2016b), it can only
reveal 'part of the picture'.
4.4. Strengths and limitations of this review
We followed PRISMA guidelines and used a comprehensive sys-
tematic search strategy to avoid missing relevant studies. We did not
narrow our eligibility criteria to studies using particular research de-
signs (e.g. case/control studies), samples (e.g. only clinical or healthy)
or only young or older participants. We also included studies using any
dMRI technique (e.g. TBSS, VBA or tractography-based ROI) or analysis
(e.g. structural connectivity) to enhance our ability to evaluate how AD
genetic risk is manifest in white matter. Unfortunately, any eligible
studies in non-English language journals would have been overlooked.
The methodology was heterogeneous. Even when the same techniques
are applied there can be differences between scanners (Vollmar et al.,
2010), and although some standardisation exists for DTI acquisition,
other designs are largely ad hoc and can vary between centres. This
meant that we were unable to perform a meta-analysis, could not es-
tablish the magnitude of effect sizes or assess for publication bias. The
studies included in this review had a number of limitations. Some of the
studies were probably underpowered. Authors often failed to describe
sample ascertainment, making it more difficult to contextualise their
results. The majority of studies included used either TBSS or VBA,
which have a number of limitations, such as the requirement for spatial
smoothing (Jones et al., 2005; Jones and Cercignani, 2010; Edden and
Jones, 2011).
4.5. Potential clinical applications
As this review demonstrates, there is evidence that dMRI markers
can detect changes in white matter microstructure in those with in-
creased genetic risk of AD. The evidence suggests that some white
matter tracts may be more sensitive than others, offering a possible
marker of incipient disease. dMRI may also prove to be a useful tool for
monitoring disease progression. However, dMRI presents a number of
methodological challenges, and the biological changes that underpin
alterations in dMRI signal are uncertain. However, with continuous
improvements in imaging technology (McNab et al., 2013; Jones et al.,
2018), and biophyiscal modeling (Novikov, Kiselev and Jespersen,
2018), we are likely to deepen our understanding of those biological
underpinnings. Conventional T1- and T2- weighted images give estab-
lished diagnostic markers and are widely used in clinical practice
(Frisoni et al., 2010). The utility of dMRI as an adjunct to traditional
structural assessment is as yet unproven. Beyond that, there are also
practical challenges, such as the length of acquisition protocols, and a
lack of standardisation of models, acquisition and analysis.
Fig. 2. The change in the diffusion signal (isotropic to anisotropic diffusion) can
result from multiple different pathologies. States that can produce the same
signal change include axonal loss, demyelination, axonal growth or edema.
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5. Conclusions
Despite some methodological limitations, the majority of the studies
presented in this review demonstrate significant associations between
AD genetic risk and diffusivity in white matter tracts. Specifically, lower
FA and increased MD, RD and LD were found in a number of white
matter tracts. This review emphasises the need for longitudinal studies
of AD genetic risk to fully characterise white matter changes related to
neurodegeneration across the lifespan. It is probable that very early
pathology will be more amenable to therapeutic intervention.
Therefore, early detection and pre-symptomatic treatment are vital. As
acquisition and analysis techniques develop, dMRI is able to provide
increasingly detailed information about the structure of white matter
and brain connections and may develop useful biomarkers for AD pa-
thology in future.
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